NCT01204541已完成不适用
A Single-Center Pilot Study to Assess Macular Function
ORA, Inc.0 个研究点目标入组 24 人开始时间: 2010年9月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
This study seeks to evaluate a novel endpoint for future dry AMD clinical trials.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 20 Years 至 90 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Subjects in good health aged 20-29 or 60-90 years (normal cohorts)
- •Subjects with early non-exudative age-related macular degeneration (AMD cohort)
排除标准
- •Enrollment in a investigational drug or device study and have used an investigational drug or device within 7 days of enrollment into this study
研究者
相似试验
Unknown
不适用
Long-Term Efficacy in AMD of Rheopheresis in North AmericaMacular DegenerationNCT00380172OccuLogix120
Unknown
不适用
Evaluation of Dry Eye Disease's Signs in Patients Who Were Administered Intravitreal Anti-VEGF InjectionsDry Eye SyndromesNCT06317922Francesco Bandello60
撤回
2 期
Intravitreal AAVCAGsCD59 for Advanced Dry Age-related Macular Degeneration (AMD) With Geographic Atrophy (GA)Dry Age-related Macular DegenerationGeographic AtrophyGene TherapyIntravitreal InjectionNCT04358471Hemera Biosciences
已完成
4 期
Wet Macular Degeneration Study to Compare Ranibizumab or Bevacizumab to AfliberceptExudative Macular DegenerationNCT01617148Rishi Singh26
已完成
不适用
A Study to Evaluate the Safety and Effectiveness Assessments of Restylane-Defyne for Punctual OcclusionDry EyeNCT04022382John C Meyer, MD17